154 related articles for article (PubMed ID: 7681044)
21. Pertussis toxin effects on T lymphocytes are mediated through CD3 and not by pertussis toxin catalyzed modification of a G protein.
Gray LS; Huber KS; Gray MC; Hewlett EL; Engelhard VH
J Immunol; 1989 Mar; 142(5):1631-8. PubMed ID: 2521885
[TBL] [Abstract][Full Text] [Related]
22. Interaction of Bordetella pertussis virulence components with neutrophils: effect on chemiluminescence induced by a chemotactic peptide and by intact bacteria.
Craig FF; Lackie JM; Parton R; Freer JH
J Gen Microbiol; 1988 Aug; 134(8):2201-11. PubMed ID: 2908118
[TBL] [Abstract][Full Text] [Related]
23. Interaction of pertussis toxin with cells and model membranes.
Hausman SZ; Burns DL
J Biol Chem; 1992 Jul; 267(19):13735-9. PubMed ID: 1618869
[TBL] [Abstract][Full Text] [Related]
24. Membrane localization of the S1 subunit of pertussis toxin in Bordetella pertussis and implications for pertussis toxin secretion.
Farizo KM; Fiddner S; Cheung AM; Burns DL
Infect Immun; 2002 Mar; 70(3):1193-201. PubMed ID: 11854200
[TBL] [Abstract][Full Text] [Related]
25. Description of a hybridoma bank towards Bordetella pertussis toxin and surface antigens.
Poolman JT; Kuipers B; Vogel ML; Hamstra HJ; Nagel J
Microb Pathog; 1990 Jun; 8(6):377-82. PubMed ID: 1980000
[TBL] [Abstract][Full Text] [Related]
26. Proteolytic cleavage of pertussis toxin S1 subunit is not essential for its activity in mammalian cells.
Carbonetti NH; Mays RM; Artamonova GV; Plaut RD; Worthington ZE
BMC Microbiol; 2005 Feb; 5():7. PubMed ID: 15691377
[TBL] [Abstract][Full Text] [Related]
27. Site-specific alterations in the B oligomer that affect receptor-binding activities and mitogenicity of pertussis toxin.
Lobet Y; Feron C; Dequesne G; Simoen E; Hauser P; Locht C
J Exp Med; 1993 Jan; 177(1):79-87. PubMed ID: 8418210
[TBL] [Abstract][Full Text] [Related]
28. Role of ADP-ribosyltransferase activity of pertussis toxin in toxin-adhesin redundancy with filamentous hemagglutinin during Bordetella pertussis infection.
Alonso S; Pethe K; Mielcarek N; Raze D; Locht C
Infect Immun; 2001 Oct; 69(10):6038-43. PubMed ID: 11553541
[TBL] [Abstract][Full Text] [Related]
29. Regulatory mechanism of expression of LPS binding site(s) and signaling events by LPS in macrophages.
Akagawa KS; Kamoshita K; Tomita T; Yasuda T; Tokunaga T
Adv Exp Med Biol; 1990; 256():467-80. PubMed ID: 1691581
[No Abstract] [Full Text] [Related]
30. A pertussis toxin-sensitive G-protein mediates some aspects of insulin action in BC3H-1 murine myocytes.
Luttrell L; Kilgour E; Larner J; Romero G
J Biol Chem; 1990 Oct; 265(28):16873-9. PubMed ID: 1698770
[TBL] [Abstract][Full Text] [Related]
31. Functional modification by cholera-toxin-catalyzed ADP-ribosylation of a guanine-nucleotide-binding regulatory protein serving as the substrate of pertussis toxin.
Iiri T; Ohoka Y; Ui M; Katada T
Eur J Biochem; 1991 Dec; 202(2):635-41. PubMed ID: 1662135
[TBL] [Abstract][Full Text] [Related]
32. Binding of ATP by pertussis toxin and isolated toxin subunits.
Hausman SZ; Manclark CR; Burns DL
Biochemistry; 1990 Jul; 29(26):6128-31. PubMed ID: 1698450
[TBL] [Abstract][Full Text] [Related]
33. Protease treatment of pertussis toxin identifies the preferential cleavage of the S1 subunit.
Krueger KM; Mende-Mueller LM; Barbieri JT
J Biol Chem; 1991 May; 266(13):8122-8. PubMed ID: 1850738
[TBL] [Abstract][Full Text] [Related]
34. The use of microcalorimetry to characterize tetanus neurotoxin, pertussis toxin and filamentous haemagglutinin.
Krell T; Greco F; Nicolaï MC; Dubayle J; Renauld-Mongénie G; Poisson N; Bernard I
Biotechnol Appl Biochem; 2003 Dec; 38(Pt 3):241-51. PubMed ID: 12911336
[TBL] [Abstract][Full Text] [Related]
35. Effect of protein kinase C inhibitor (H-7) and calmodulin antagonist (W-7) on pertussis toxin-induced IL-1 production by human adherent monocytes. Comparison with lipopolysaccharide as a stimulator of IL-1 production.
Taniguchi H; Sakano T; Hamasaki T; Kashiwa H; Ueda K
Immunology; 1989 Jun; 67(2):210-5. PubMed ID: 2787778
[TBL] [Abstract][Full Text] [Related]
36. Immunomodulation of murine experimental autoimmune encephalomyelitis by pertussis toxin: the protective activity, but not the disease-enhancing activity, can be attributed to the nontoxic B-oligomer.
Ben-Nun A; Mendel I; Kerlero de Rosbo N
Proc Assoc Am Physicians; 1997 Mar; 109(2):120-5. PubMed ID: 9069580
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of pertussis toxin binding to model receptors by antipeptide antibodies directed at an antigenic domain of the S2 subunit.
Schmidt MA; Schmidt W
Infect Immun; 1989 Dec; 57(12):3828-33. PubMed ID: 2478479
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of PtlC, an essential component of the pertussis toxin secretion system.
Cook DM; Farizo KM; Burns DL
Infect Immun; 1999 Feb; 67(2):754-9. PubMed ID: 9916087
[TBL] [Abstract][Full Text] [Related]
39. Molecular characterization of the in vitro activation of pertussis toxin by ATP.
Krueger KM; Barbieri JT
J Biol Chem; 1993 Jun; 268(17):12570-8. PubMed ID: 8509398
[TBL] [Abstract][Full Text] [Related]
40. Investigation of the lectin-like binding domains in pertussis toxin using synthetic peptide sequences. Identification of a sialic acid binding site in the S2 subunit of the toxin.
Heerze LD; Chong PC; Armstrong GD
J Biol Chem; 1992 Dec; 267(36):25810-5. PubMed ID: 1281475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
